Can I read Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer A Phase III Trial - InTACT 2 on EtoBox?

Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer A Phase III Trial - InTACT 2 by 聪聪 柳 is a document available to read on EtoBox.

What is Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer A Phase III Trial - InTACT 2 about?

The INTACT 2 trial evaluated the efficacy of gefitinib in combination with paclitaxel and carboplatin in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC). The study found no significant difference in overall survival, time to progression, or response rate between gefitinib and placebo groups, although gefitinib was well tolerated. A subset analysis suggested a potential maintenance effect for patients with adenocarcinoma receiving prolonged chemotherapy, but overall, gefitinib di

Author

聪聪 柳

Language

EN